Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Adobe
ADBE
|
$454M |
| 2 |
CRH
CRH
|
$432M |
| 3 |
Broadcom
AVGO
|
$427M |
| 4 |
Philip Morris
PM
|
$398M |
| 5 |
Kenvue
KVUE
|
$301M |
Top Sells
| 1 |
Exxon Mobil
XOM
|
$475M |
| 2 |
Microsoft
MSFT
|
$472M |
| 3 |
Visa
V
|
$414M |
| 4 |
Merck
MRK
|
$384M |
| 5 |
Meta Platforms (Facebook)
META
|
$380M |
Sector Composition
| 1 | Technology | 21.92% |
| 2 | Healthcare | 11.83% |
| 3 | Financials | 11.72% |
| 4 | Industrials | 11.17% |
| 5 | Consumer Discretionary | 10.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3576
X4 Pharmaceuticals
XFOR
$83.7M
| $88.3K | ﹤0.01% |
2,701
+316
| +13% | +$10.3K |
|
3577
Ovid Therapeutics
OVID
$91.7M
| $88.3K | ﹤0.01% |
22,987
| – | – |
|
3578
Definitive Healthcare
DH
$417M
| $88.2K | ﹤0.01% |
11,040
+325
| +3% | +$2.6K |
|
3579
Vuzix
VUZI
$169M
| $88.2K | ﹤0.01% |
24,300
-11,309
| -32% | -$41.1K |
|
3580
Forge Global Holdings
FRGE
$238M
| $86K | ﹤0.01% |
2,824
| – | – |
|
|
SNMP
3581
DELISTED
Evolve Transition Infrastructure LP
SNMP
| $85.9K | ﹤0.01% |
+58,252
| New | +$85.9K |
|
3582
Altimmune
ALT
$314M
| $85.9K | ﹤0.01% |
33,029
+4,956
| +18% | +$12.9K |
|
3583
Karyopharm Therapeutics
KPTI
$59.5M
| $85.5K | ﹤0.01% |
4,254
+618
| +17% | +$12.4K |
|
|
LVOX
3584
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
| $85K | ﹤0.01% |
25,460
| – | – |
|
|
XYF
3585
X Financial
XYF
$626M
| $84.1K | ﹤0.01% |
+20,573
| New | +$84.1K |
|
3586
FibroGen
FGEN
$46.2M
| $83.7K | ﹤0.01% |
3,882
+1,765
| +83% | +$38.1K |
|
3587
Vivid Seats
SEAT
$99.5M
| $83.4K | ﹤0.01% |
649
+25
| +4% | +$3.21K |
|
3588
NextDecade
NEXT
$2.75B
| $83.3K | ﹤0.01% |
16,266
-125,051
| -88% | -$640K |
|
3589
Cartesian Therapeutics
RNAC
$265M
| $82.7K | ﹤0.01% |
2,601
-40
| -2% | -$1.27K |
|
3590
Mersana Therapeutics
MRSN
$35M
| $82.6K | ﹤0.01% |
2,601
+1,056
| +68% | +$33.5K |
|
3591
Nano X Imaging
NNOX
$239M
| $81.9K | ﹤0.01% |
12,491
+489
| +4% | +$3.21K |
|
|
XNET
3592
Xunlei
XNET
$459M
| $80.3K | ﹤0.01% |
+49,542
| New | +$80.3K |
|
|
MOND
3593
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $79.9K | ﹤0.01% |
22,381
| – | – |
|
3594
AlTi Global
ALTI
$426M
| $79.9K | ﹤0.01% |
11,474
-68,968
| -86% | -$480K |
|
3595
Immuneering
IMRX
$234M
| $78.7K | ﹤0.01% |
10,249
+24
| +0.2% | +$184 |
|
|
SY
3596
So-Young International
SY
$346M
| $78.6K | ﹤0.01% |
75,178
+2,677
| +4% | +$2.8K |
|
3597
Atomera
ATOM
$103M
| $78.1K | ﹤0.01% |
12,473
+1,582
| +15% | +$9.9K |
|
3598
Lineage Cell Therapeutics
LCTX
$276M
| $77.8K | ﹤0.01% |
65,892
| – | – |
|
3599
Frontier Group Holdings
ULCC
$1.17B
| $77.5K | ﹤0.01% |
16,012
| – | – |
|
3600
ImmunityBio
IBRX
$2.27B
| $76.9K | ﹤0.01% |
45,473
+792
| +2% | +$1.34K |
|